Clinical trial
A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes…
NCT00212641 · Ono Pharma USA Inc, Industry · Completed
Key facts
| NCT number | NCT00212641 |
|---|---|
| Title | A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus |
| Official title | Randomized Double-Blind Placebo-Controlled Pharmacodynamic Evaluation of ONO-5129 in Patients With Treatment Naive Type 2 Diabetes Mellitus |
| Lead sponsor | Ono Pharma USA Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | ONO-5129 |
| Enrollment | 105 |
| Start date | Jun 1, 2005 |
| Primary completion | Oct 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 11, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: